We Share Science

Video abstract of review paper "The potential benefit of stem cell therapy after stroke: an update" published in the open access journal Vascular Health and Risk Management by Soma Banerjee, Deborah A Williamson, Nagy Habib, and Jeremy Chataway. Abstract: Stroke is a leading cause of death and disability worldwide. Stem cell therapy is an emerging therapeutic modality with evidence of significant benefits in preclinical stroke models. A number of phase I and II clinical trials have now been completed, with several more currently under way. Translation to the bedside, however, remains a long way off, and there are many questions that remain unanswered. This review will summarize the current evidence and ongoing clinical trials worldwide, and explore the challenges to making this a realistic treatment option for the future. Read this review and sign up to receive the Vascular Health and Risk Management journal: http://www.dovepress.com/the-potential-benefit-of-stem-cell-therapy-after-stroke-an-update-peer-reviewed-article